New Pathway For Repairing the Damage of Multiple Sclerosis
The study led by researchers at Case Western Reserve University School of Medicine, suggests new drug targets and potent early-stage drug candidates could lead to regenerative medicines for multiple sclerosis and other debilitating neurological diseases